Warfarin Tablet

Free

Warfarin Sodium Tablets IP 1 mg

Each Uncoated Tablet Contains
Warfarin Sodium Clathrate IP 1 mg
Excipients – q.s

Warfarin Sodium Tablets IP 2 mg

Each Uncoated Tablet Contains
Warfarin Sodium Clathrate IP 2 mg
Excipients – q.s

Warfarin Sodium Tablets IP 5 mg

Each Uncoated Tablet Contains
Warfarin Sodium Clathrate IP 5 mg
Excipients – q.s

Warfarin tablets BP 1 mg

Each Uncoated Tablet contains :
Warfarin tablets BP 1 mg

Excipient -QS

Warfarin tablets BP 2 mg

Each Uncoated Tablet contains :
Warfarin tablets BP 2 mg

Excipient -QS

Warfarin tablets BP 3 mg

Each Uncoated Tablet contains :
Warfarin tablets BP 3 mg

Excipient -QS

Warfarin Sodium Tablets BP 5 mg

Each Uncoated Tablet Contain :

WARFARIN SODIUM BP (5,0 mg)
EXCIPIENTS (In House) (- OS)

 

Usage: – Prevent blood clots from forming or growing larger

Category: –  Hypertensive / Cardiac Drugs

Therapeutic category: – Hypertensive

SKU: Warfarin Sodium Tablets Category: Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Description

Warfarin Sodium Tablets (1 mg / 2 mg / 5 mg)

Healthy Inc is a premier global provider of high-precision cardiovascular and antithrombotic therapies. We provide premium Warfarin Sodium Tablets, manufactured in WHO–GMP certified specialized solid dosage units. As a primary oral anticoagulant for the prevention of thromboembolic complications, this product is a vital export for cardiology clinics, hematology centers, and Ministry of Health (MOH) tenders in Southeast Asia, Africa, and the Middle East.


Product Overview

Warfarin is a synthetic coumarin-derivative anticoagulant. It is a Narrow Therapeutic Index (NTI) drug, specifically engineered to provide long-term prophylaxis against blood clot formation by interfering with the hepatic synthesis of Vitamin K-dependent clotting factors.

The “Coagulation Control” Specialist:

  • Mechanism of Action: Warfarin inhibits the enzyme Vitamin K Epoxide Reductase (VKORC1). This prevents the recycling of oxidized Vitamin K back to its reduced form, which is essential for the carboxylation and activation of Clotting Factors II (Prothrombin), VII, IX, and X, as well as anticoagulant proteins C and S.
  • Precise Thrombus Prevention: It is highly effective in preventing the extension of existing thrombi and the formation of new clots in high-risk conditions such as Atrial Fibrillation or following heart valve replacement.
  • Predictable Pharmacokinetics: While it has a delayed onset of action (requiring 3–5 days for full clinical effect), its long half-life provides stable, continuous anticoagulation once a steady state is reached.

Technical & Manufacturing Specifications

Formulated for absolute dose uniformity—critical for Narrow Therapeutic Index medications.

Technical Metric Specification Standard
Active Ingredient Warfarin Sodium Clathrate BP / USP / IP
Dosage Form Immediate Release Tablets (Color-coded)
Available Strengths 1 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg
HS Code 3004.90.99 (Anticoagulants) / 2932.20.00
Packaging HDPE Bottles with Desiccant or Alu-Alu Blisters

Manufacturing Authority

Marketed and Distributed by Healthy Inc from ISO 9001:2015 certified units.

  • Color-Coding Precision: To prevent patient dosing errors, our Warfarin tablets are color-coded by strength according to international standards (e.g., Pink for 1mg, Lavender for 2mg, Peach for 5mg).
  • Content Uniformity (NTI Standard): Because small changes in dose can lead to therapeutic failure or hemorrhage, we utilize validated high-precision blending to ensure 100% uniformity across every tablet in a batch.
  • Stability Validation: Validated for Zone IVb climates. Our packaging is designed to protect the hygroscopic Warfarin Sodium from moisture, ensuring the drug remains potent for its entire 36-month shelf life.

Therapeutic Indications & Clinical Symptoms

  • Venous Thromboembolism: Treatment and prophylaxis of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).
  • Atrial Fibrillation (AFib): Prevention of systemic embolism and ischemic stroke in patients with chronic AFib.
  • Prosthetic Heart Valves: Long-term anticoagulation following mechanical heart valve replacement.
  • Post-Myocardial Infarction: Reduction in the risk of death, recurrent MI, and thromboembolic events.

Dosage & Administration

  • Monitoring: Dosage must be individualized based on the International Normalized Ratio (INR). The typical target INR range is 2.0 to 3.0.
  • Dietary Interaction: Patients must maintain a consistent intake of Vitamin K-rich foods (like leafy greens) to avoid fluctuations in INR.
  • Safety Note: High Bleeding Risk. Contraindicated in pregnancy (teratogenic). Antidote for overdosage is Vitamin K1 (Phytonadione) or Prothrombin Complex Concentrate (PCC).

Global Export & Contract Manufacturing Services

Healthy Inc is a verified Anticoagulant Exporter in Mumbai, catering to Cardiovascular Specialty Centers and Ministry of Health Tenders. We offer Third Party Manufacturing for Warfarin with full CTD Dossier and COPP support. Our logistics network ensures secure transit to Vietnam, Nigeria, UAE, and the Philippines, providing WHO-GMP quality at competitive B2B prices.

Commercial Inquiries

WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in